{"id":196429,"date":"2023-11-20T12:27:40","date_gmt":"2023-11-20T16:27:40","guid":{"rendered":"http:\/\/stateofthenation.co\/?p=196429"},"modified":"2023-11-20T12:27:40","modified_gmt":"2023-11-20T16:27:40","slug":"operation-covid-19-when-big-medical-colluded-with-big-pharma-to-murder-and-or-severely-injure-us-all","status":"publish","type":"post","link":"http:\/\/stateofthenation.co\/?p=196429","title":{"rendered":"

OPERATION COVID-19: When Big Medical<\/i> colluded with Big Pharma<\/i> to murder and\/or severely injure us all.<\/b><\/h2>"},"content":{"rendered":"

New Study: Death Following COVID Vaccination<\/h1>\n

JON RAPPOPORT<\/p>\n

I\u2019m told the study is being held back from journal publication.<\/p>\n

You can find it here<\/a>.<\/p>\n

\u201cAdverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia\u201d<\/em> \u2014 PubMed (nih.gov)<\/p>\n

The Study:<\/p>\n

Background and objectives:\u00a0Since publishing successful clinical trial results of mRNA coronavirus disease 2019 (COVID-19) vaccines in December 2020, multiple reports have arisen about cardiovascular complications following the mRNA vaccination. This study provides an in-depth account of various cardiovascular adverse events reported after the mRNA vaccines\u2019 first or second dose including pericarditis\/myopericarditis, myocarditis, hypotension, hypertension, arrhythmia, cardiogenic shock, stroke, myocardial infarction\/STEMI, intracranial hemorrhage, thrombosis (deep vein thrombosis, cerebral venous thrombosis, arterial or venous thrombotic events, portal vein thrombosis, coronary thrombosis, microvascular small bowel thrombosis), and pulmonary embolism.<\/p>\n

Methods:\u00a0A systematic review of original studies reporting confirmed cardiovascular manifestations post-mRNA COVID-19 vaccination was performed. Following the PRISMA guidelines, electronic databases (PubMed, PMC NCBI, and Cochrane Library) were searched until January 2022. Baseline characteristics of patients and disease outcomes were extracted from relevant studies.<\/p>\n

Results:\u00a0A total of 81 articles analyzed confirmed cardiovascular complications post-COVID-19 mRNA vaccines in 17,636 individuals and reported 284 deaths with any mRNA vaccine. Of 17,636 cardiovascular events with any mRNA vaccine, 17,192 were observed with the BNT162b2 (Pfizer-BioNTech) vaccine, 444 events with mRNA-1273 (Moderna). Thrombosis was frequently reported with any mRNA vaccine (n = 13,936), followed by stroke (n = 758), myocarditis (n = 511), myocardial infarction (n = 377), pulmonary embolism (n = 301), and arrhythmia (n = 254). Stratifying the results by vaccine type showed that thrombosis (80.8%) was common in the BNT162b2 cohort, while stroke (39.9%) was common with mRNA-1273 for any dose. The time between the vaccination dosage and the first symptom onset averaged 5.6 and 4.8 days with the mRNA-1273 vaccine and BNT162b2, respectively. The mRNA-1273 cohort reported 56 deaths compared to the 228 with BNT162b2, while the rest were discharged or transferred to the ICU.<\/p><\/blockquote>\n

On his Substack, Dr.<\/p>\n

Peter McCullough, MD<\/a><\/div>\n

, commenting on the study, writes: \u201cKeep in mind usually [less than] 50 deaths with a widely used, novel product prompts a worldwide recall. To have 284 well described deaths as a result of cardiovascular and or thrombotic complications is a striking finding in the medical literature for products that are still on the market and promoted by public health agencies all over the world.\u201d<\/p>\n

In 1976, with 25% of the US population vaccinated against the supposed Fort Dix Swine Flu, and 32 deaths as result of the vaccine\u2014the 32 figure was no doubt disputed as \u201ctoo high\u201d by the CDC at the time\u2014the entire vaccination program was halted and canceled.<\/p>\n

Traditional medical thinking on vaccine-related deaths used to be: If we see a few deaths, it means there are many more we aren\u2019t seeing.<\/p>\n

Not now.<\/p>\n

\n
\n
\n
\n
\n
<\/div>\n